Clinical Trial Update: Lazanda in Cancer Patients Receiving Palliative Radiation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Lazanda used in cancer patients receiving palliative radiation, terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases

Drugs mentioned

• Lazanda

Snippet

Sponsor: Joseph Ma | Conditions: Bone Metastases | Phase 2 | Status: TERMINATED | Results posted: 2019-07-23